KalVista Pharmaceuticals, Inc.
2022 Q1 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 81,394 | 2.2% | 5,039,867 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 61,386 | 1.8% | 5,039,867 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 55,257 | 2.2% | 4,887,867 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 56,406 | 2.6% | 4,887,867 | 3/31/2025 |
| 2024 Q4 | 2/18/2025 | 41,400 | 1.7% | 4,887,867 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 42,706 | 1.7% | 3,687,867 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 43,443 | 2.0% | 3,687,867 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 43,738 | 1.8% | 3,687,867 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 44,373 | 2.4% | 3,622,294 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 31,190 | 2.1% | 3,238,859 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 29,150 | 1.7% | 3,238,859 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 25,457 | 1.8% | 3,238,859 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 21,895 | 1.4% | 3,238,859 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 22,813 | 1.8% | 1,572,192 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 15,470 | 1.5% | 1,572,192 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 23,174 | 2.0% | 1,572,192 | 3/31/2022 |